{ "BXCL501 for Alcohol Use Disorder and PTSD", "This study is testing a sublingual (under the tongue) film called Dexmedetomidine HCl (BXCL501) to see if it's safe and potentially effective for people with Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD). Researchers want to see if BXCL501 can help with anxiety and doesn't cause too many side effects. You might be able to join if you are a veteran or non-veteran between 21 and 65 years old, can read and write English, and are willing to follow study procedures. The study will measure changes in blood pressure and anxiety levels over 28 days, and also track any side effects. The study is currently recruiting 10 participants.", "design": "This is a Phase 1b, open-label (meaning you and the study staff will know what treatment you are receiving), single-arm study, meaning all participants will receive the study drug. It aims to enroll at least 10 participants.", "commitments": "You would receive BXCL501 as a sublingual film for 28 days, with the dose increasing over the first 6 days. You would need to comply with all study procedures and be available for the study's duration.", "compensation": "Not stated in the trial record.", "follow_up": "Your blood pressure, anxiety levels, and any adverse events will be monitored from day 1 through day 28.", }

Study design

Not specified.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.